Tang Capital Partners

blocks with checks and crosses
Biotech

Concentra scoops up near-defunct Allakos

Tang Capital Partners-owned Concentra inked an Allakos acquisition agreement after being denied by Pliant Therapeutics and Acelyrin.
Zoey Becker Apr 2, 2025 5:05pm
poison pill toxic poison

Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms

Mar 14, 2025 10:01am
blocks with checks and crosses

Acelyrin turns down surprise Concentra buyout offer

Mar 4, 2025 10:26am
illustration of two arrows going in opposite directions

Concentra curveball intrudes on Acelyrin-Alumis merger

Feb 21, 2025 7:35am
Withdraw cancel rip up application

Kezar rejects Concentra buyout that 'undervalues' the biotech

Oct 17, 2024 9:10am
Pac man eat MA deal buy sell merger

With Kezar in lupus limbo, Concentra spies potential acquisition

Oct 9, 2024 7:10am